Safety, Tolerability and PK Study of AK0529 in Healthy Human

Clinical trial NCT02297594 · COMPLETED

Trial details

NCT number: NCT02297594
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2014-10-01
Primary completion: 2015-06-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.